cis-Urocanic acid enhances prostaglandin E2 release and apoptotic cell death via reactive oxygen species in human keratinocytes

J Invest Dermatol. 2011 Jun;131(6):1262-71. doi: 10.1038/jid.2011.37. Epub 2011 Mar 17.

Abstract

Urocanic acid (UCA) is a major UVR-absorbing skin molecule that undergoes trans to cis photoisomerization in the epidermis following UVR exposure. Murine studies have established that cis-UCA is an important mediator of UVR-induced immune suppression, but little is known about its signaling pathway. We have previously demonstrated that treatment of normal human epidermal keratinocytes with cis-UCA resulted in increased synthesis of prostaglandin E(2) (PGE(2)) and cell death. Here, using immortalized human keratinocytes, we report that cis-UCA but not trans-UCA generates reactive oxygen species (ROS) in a dose-dependent manner and that the natural antioxidant α-tocopherol can reduce this ROS generation, subsequent PGE(2) release, and apoptotic cell death. Western blot analysis revealed that cis-UCA leads to a transient phosphorylation of EGFR as well as downstream mitogen-activated protein kinases (MAPKs), extracellular signal-regulated kinase (ERK) and p38. Pharmacological inhibition of their activity attenuated PGE(2) release induced by cis-UCA. After transient activation, cis-UCA downregulated EGFR protein expression that corresponded to activation of caspase-3. In addition, pretreatment with α-tocopherol inhibited EGFR downregulation and caspase-3 activation induced by cis-UCA. These results suggest that cis-UCA exerts its effects on human keratinocytes via intracellular ROS generation that modulates EGFR signaling and subsequently induces PGE(2) synthesis and apoptotic cell death.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Caspase 3 / physiology
  • Cells, Cultured
  • Cyclooxygenase 2 / physiology
  • Dinoprostone / biosynthesis*
  • ErbB Receptors / drug effects
  • ErbB Receptors / physiology
  • Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors
  • Humans
  • Keratinocytes / drug effects*
  • Keratinocytes / metabolism
  • Reactive Oxygen Species / metabolism*
  • Urocanic Acid / pharmacology*
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors

Substances

  • Reactive Oxygen Species
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • ErbB Receptors
  • Extracellular Signal-Regulated MAP Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Caspase 3
  • Urocanic Acid
  • Dinoprostone